Jan 08, 2026
Aehr Test Systems Stock Drops After Q2 Revenue Misses Estimates

Aehr Test Systems (NASDAQ:AEHR) shares fell in Thursday's extended trading after the company released its second-quarter earnings report, missing revenue estimates. Here's a look at the key figures from the quarter.  AEHR stock is moving. Watch the price action here. The…

Jan 08, 2026
Bloom Energy Shares Jump Thursday: What’s Driving The Action?

Bloom Energy Corp (NYSE:BE) shares were up on Thursday afternoon following a recent credit agreement that bolstered investor confidence. The stock moved higher as the broader market experienced modest gains. Bloom Energy shares are powering higher. What’s fueling BE momentum? Why…

Jan 08, 2026
Micron’s Pricing Power Looks Unstoppable As AI Demand Outruns Supply

Micron Technology Inc. (NASDAQ:MU) is riding an AI-fueled memory squeeze, with JP Morgan saying demand for DRAM, especially HBM, should continue to outstrip supply past 2026, keeping pricing firm and reinforcing its bullish stance on the stock. JP Morgan analyst…

Jan 08, 2026
Enliven Therapeutics Early Leukemia Drug Results Impress, Stock Soars

Enliven Therapeutics Inc. (NASDAQ:ELVN) stock is trading higher on Thursday, with a session volume of 6.61 million compared to the average volume of 631.52 thousand as per data from Benzinga Pro. The clinical-stage biopharmaceutical company shared encouraging initial data from…

Jan 08, 2026
MoonLake Says FDA May Allow Skin Drug Filing Without New Trials, Stock Soars

MoonLake Immunotherapeutics (NASDAQ:MLTX) on Thursday received U.S. Food and Drug Administration (FDA) feedback regarding the clinical evidence strategy for Sonelokimab (SLK) in Hidradenitis Suppurativa (HS), based on the Type B meeting requested by MoonLake. SLK was associated with significant improvements…